术前对侧肺受照剂量与局部晚期非小细胞肺癌三联治疗患者术后肺毒性相关
回顾性分析2008年3月至2016年10月接受三联治疗(放化疗后手术)的46例非小细胞肺癌患者,评估对侧未受累肺辐射跌落剂量参数与术后肺部毒性的关联。对侧肺V20≥7%与V10≥20%者任何级别肺毒性发生率更高,全肺切除/双肺叶切除与2级及以上肺毒性相关。
要点
- 对侧肺V20≥7%者任何级别肺毒性发生率90%(9例) vs V20<7%者41.7%(15例),P=0.01。
- 对侧肺V10≥20%者任何级别肺毒性发生率80%(12例) vs V10<20%者38.7%(12例),P=0.01。
- 全肺切除/双肺叶切除与2级及以上肺毒性相关(P=0.04)。
核心结论
- 对侧未受累肺接受较高辐射跌落剂量体积参数(V20≥7%和V10≥20%)的患者任何级别术后肺毒性发生率更高。
- 限制对侧未受累肺的辐射跌落剂量可能是减少三联治疗患者术后毒性的重要可调放射参数。
研究设计与样本
- 回顾性分析2008年3月至2016年10月接受三联治疗(放化疗后手术切除)且有可恢复数字放疗计划的非小细胞肺癌患者。
- 共纳入46例患者,接受调强放疗(中位剂量59.4 Gy,范围45-70 Gy)和同步铂类双药化疗后手术切除。
- 中位年龄64.9岁(范围45.6-81.6),中位随访时间1.9年(范围0.3-8.4)。
主要发现
- 24例(52.2%)发生任何级别肺毒性,14例(30.4%)发生2级及以上肺毒性。
- 对侧肺V20≥7%组任何级别肺毒性发生率90%(9例) vs V20<7%组41.7%(15例),P=0.01。
- 对侧肺V10≥20%组任何级别肺毒性发生率80%(12例) vs V10<20%组38.7%(12例),P=0.01。
- 全肺切除/双肺叶切除与2级及以上肺毒性相关(P=0.04)。
临床怎么用
- 原文未据此给出推荐;作者认为限制对侧未受累肺的辐射跌落剂量可能是减少三联治疗患者术后毒性的重要可调放射参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In patients with non-small cell lung cancer (NSCLC) who undergo trimodality therapy (chemoradiation followed by surgical resection), it is unknown whether limiting preoperative radiation dose to the uninvolved lung reduces postsurgical morbidity. This study evaluated whether radiation fall-off dose parameters to the contralateral lung that is unaffected by NSCLC are associated with postoperative complications in NSCLC patients treated with trimodality therapy. METHODS AND MATERIALS: We retrospectively reviewed NSCLC patients who underwent trimodality therapy between March 2008 and October 2016, with available restored digital radiation plans. Fischer's exact test was used to assess associations between patient and treatment characteristics and the development of treatment-related toxicity. Spearman rank correlation was used to measure the strength of association between dosimetric parameters. RESULTS: Forty-six patients were identified who received trimodality therapy with intensity modulated radiation (median, 59.4 Gy; range, 45-70) and concurrent platinum doublet chemotherapy, followed by surgical resection. The median age was 64.9 years (range, 45.6-81.6). The median follow-up time was 1.9 years (range, 0.3-8.4). Twenty-four (52.2%) patients developed any-grade pulmonary toxicity and 14 (30.4%) patients developed grade 2+ pulmonary toxicity. There was an increased incidence of any-grade pulmonary toxicity in patients with contralateral lung volume receiving at least 20 Gy (V20) ≥7% compared with <7% (90%, n = 9 vs 41.7%, n = 15; P = .01). Similarly, contralateral lung V10 ≥20% was associated with an increased rate of any-grade pulmonary toxicity compared with V10 <20% (80%, n = 12 vs 38.7%, n = 12; P = .01). Pneumonectomy/bilobectomy was associated with grade 2+ pulmonary toxicity (P = .04). CONCLUSIONS: Patients who received a higher radiation fall-off dose volume parameter (V20 ≥7% and V10 ≥20%) to the contralateral uninvolved lung had a higher incidence of any-grade postoperative pulmonary toxicity. Limiting radiation fall-off dose to the uninvolved lung may be an important modifiable radiation parameter in limiting postoperative toxicity in trimodality patients.
引用
- Guo W, Hui X, Alfaifi S, et al. Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapy. Pract Radiat Oncol. 2018. PMID: 29960625. doi:10.1016/j.prro.2018.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。